Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL23234322 | 0.95 | IDO1 (0.46) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL31163835 | 0.93 | IDO1 (0.47) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL6097552 | 0.89 | IDO1 (0.53) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL18171754 | 0.88 | IDO1 (0.57) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL18171753 | 0.88 | IDO1 (0.57) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL6097310 | 0.85 | IDO1 (0.50) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL6093804 | 0.85 | IDO1 (0.50) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL18171748 | 0.84 | IDO1 (0.61) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL6095701 | 0.81 | IDO1 (0.50) | IDO1CHRM3ALDH1A1PARP10TAAR1 | |
| SCHEMBL14948690 | 0.81 | IDO1 (0.50) | IDO1CHRM3ALDH1A1PARP10TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110114363-B | Synthesis of benzyl oxyphenoxyphenol ligand | 尤尼威蒂恩技术有限责任公司 | 2023-01-20 | — | — | CN | claimed |
| EP-3565821-B1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECH LLC (US) | 2021-04-21 | — | — | EP | claimed |
| US-10815255-B2 | Synthesis of benzyloxyphenoxy phenol ligands | UNIVATION TECHNOLOGIES, LLC (US) | 2020-10-27 | — | — | US | claimed |
| US-20190352314-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2019-11-21 | — | — | US | claimed |
| EP-3565821-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | Univation Technologies, LLC (US) | 2019-11-13 | — | — | EP | claimed |
| WO-2018129235-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2018-07-12 | — | — | WO | claimed |
| CN-110114363-B | Synthesis of benzyl oxyphenoxyphenol ligand | 尤尼威蒂恩技术有限责任公司 | 2023-01-20 | — | — | CN | disclosed |
| EP-3565821-B1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECH LLC (US) | 2021-04-21 | — | — | EP | disclosed |
| EP-3565821-B1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECH LLC (US) | 2021-04-21 | — | — | EP | disclosed |
| US-10815255-B2 | Synthesis of benzyloxyphenoxy phenol ligands | UNIVATION TECHNOLOGIES, LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-10815255-B2 | Synthesis of benzyloxyphenoxy phenol ligands | UNIVATION TECHNOLOGIES, LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-20190352314-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2019-11-21 | — | — | US | disclosed |
| US-20190352314-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2019-11-21 | — | — | US | disclosed |
| EP-3565821-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | Univation Technologies, LLC (US) | 2019-11-13 | — | — | EP | disclosed |
| WO-2018129235-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2018-07-12 | — | — | WO | disclosed |
| WO-2018129235-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2018-07-12 | — | — | WO | disclosed |
| US-7034015-B2 | Interleukin 1 beta and tumour necrosis factor alpha inhibitors | LEO PHARMA A/S (DK) | 2006-04-25 | — | — | US | disclosed |
| EP-1423356-A2 | NOVEL AMINOBENZOEPHENONES | Leo Pharma A/S (DK) | 2004-06-02 | — | — | EP | disclosed |
| US-20030119902-A1 | Interleukin 1 beta and tumour necrosis factor alpha inhibitors | LEO PHARMA A/S (DK) | 2003-06-26 | — | — | US | disclosed |
| WO-2003018535-A2 | NOVEL AMINOBENZOEPHENONES | LEO PHARMA A/S (DK) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190352314-A1 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | TYR, SPR, MYB | IDO1 2302/4885CHRM3 1529/4885ALDH1A1 4076/4885 |
| US-10815255-B2 | Synthesis of benzyloxyphenoxy phenol ligands | TYR, SPR, MYB | IDO1 2302/4885CHRM3 1529/4885ALDH1A1 4076/4885 |
| US-20030119902-A1 | Interleukin 1 beta and tumour necrosis factor alpha inhibitors | IL1B, IL1A, TNF | IDO1 323/4885CHRM3 4868/4885ALDH1A1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.